Performa LTD (Us), LLC Vista Gen Therapeutics, Inc. Transaction History

Performa LTD (Us), LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$0.1 - $2.71 $8,510 - $230,621	-85,100 Reduced 94.56%	4,900 $9,000
Q1 2023 May 01, 2023	BUY	$0.12 - $0.3 $2,400 - $6,000	20,000 Added 28.57%	90,000 $10,000
Q4 2022 Feb 03, 2023	BUY	$0.09 - $0.16 $900 - $1,600	10,000 Added 16.67%	70,000 $7,000
Q3 2022 Nov 09, 2022	BUY	$0.14 - $1.07 $4,079 - $31,180	29,141 Added 94.43%	60,000 $9,000
Q2 2022 Aug 02, 2022	BUY	$0.88 - $1.73 $7,355 - $14,461	8,359 Added 37.15%	30,859 $27,000

Q1 2022 May 13, 2022	BUY	$1.14 - $2.09 $14,249 - $26,125	12,500 Added 125.0%	22,500 $28,000
Q4 2021 Jan 31, 2022	BUY	$1.67 - $2.76 $13,360 - $22,080	8,000 Added 400.0%	10,000 $0
Q3 2021 Oct 28, 2021	BUY	$2.62 - $3.45 $786 - $1,035	300 Added 17.65%	2,000 $5,000
Q2 2021 Jul 28, 2021	BUY	$1.96 - $3.15 $3,332 - $5,355	1,700 New	1,700 $5,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Performa LTD (Us), LLC, based on Form 13F filings with the SEC.

Stay updated on Performa LTD (Us), LLC with notifications on news.